Is NGVT a buy according to AI stock analysis?

NGVT AI stock analysis does not label Ingevity as an automatic buy because the recovery story is partially priced in. The stock has rallied from $39.74 to $72.07, and while the businesses are real and positioned in niche markets, the impairment charges, elevated debt, and cyclical end-market exposure mean a buyer needs confidence in margin recovery and further debt reduction.

What is the NGVT AI stock forecast?

The NGVT AI stock forecast uses scenarios, not a guaranteed target. Around the $72.07 cutoff price, the bullish scenario is roughly $90 to $105, the base scenario is roughly $60 to $80, and the bearish scenario is roughly $40 to $55, depending on end-market demand, margin recovery, debt reduction, and valuation multiples.

What technical levels matter for NGVT?

The key NGVT technical levels are the $79 to $80 resistance zone (52-week high), the $63 to $67 near-support zone (50-day moving average area), and the $55 to $58 secondary support zone (200-day moving average area). A close below $63 would weaken the near-term recovery momentum.

Can AI predict NGVT stock price?

No, AI cannot reliably predict stock prices. AI can organize filings, market data, valuation math, technical levels, and risk scenarios, but NGVT can still move sharply after earnings, impairment announcements, commodity price changes, or shifts in construction and automotive demand.

How should I use this NGVT AI trading strategy?

Use this NGVT AI trading strategy as a research checklist, not a personal instruction. Confirm live price, volume, moving averages, earnings timing, position size, stop level, and portfolio risk before making any trade.

What is the biggest risk in NGVT stock analysis?

The biggest risk in NGVT stock analysis is that the stock has already recovered significantly from its lows while debt remains elevated and the company carries impairment risk. Cyclical demand in pavement, oilfield, and automotive markets can reverse, and any additional impairment could pressure earnings and the stock.

Ingevity Corporation research snapshot

NGVT AI Stock Analysis

NGVT AI stock analysis currently reads Ingevity Corporation as a specialty chemicals company that has recovered significantly from its 2025 lows but still carries the weight of large impairment charges that distorted recent GAAP results. The analysis is not a certain price prediction. At the July 13, 2026 cutoff, the latest verified close used here was $72.07, market capitalization was about $2.51 billion, and the main question was whether Ingevity can sustain its growth in Performance Materials and Performance Chemicals segments, improve margins, and reduce leverage after the impairment-driven losses. This is informational research and not investment advice.

Current price

$72.07

Market cap

$2.51 billion

AI score

48 / 100

Rating

Cyclical chemicals, post-impairment recovery

Trend status

Recovering from 52-week lows, nearing 52-week highs

Data cutoff (updated weekly)

July 13, 2026

Informational use only. This page is not investment advice.

Research quality check

information Richness: B-level information richness. Ingevity has public SEC filings and moderate analyst coverage from a few firms. The company operates in niche specialty chemical markets where some competitive and market sizing data require reasoned estimates.
bias Check: The main AI bias risk is extrapolating the strong price recovery from the $39.74 low as confirmation of a full turnaround, without fully weighting the binary risks of further impairments, EV transition headwinds for the activated carbon automotive business, and the cyclicality of pavement preservation demand.
ai Confidence: Medium data confidence
investment Certainty: Low-medium. Ingevity has real businesses with competitive positions, but the recent impairment charges, elevated debt, and cyclical end-market exposure make the investment outcome heavily dependent on execution, raw material cost trends, and the pace of margin recovery.

Quick verdict table

Dimension	Conclusion	Confidence
Business quality	Ingevity produces specialty chemicals from pine-tree extracts and activated carbon for automotive, pavement, and industrial markets. Revenue is recurring in some areas but tied to construction cycles, auto production, and commodity raw materials.	Medium
Moat	The moat comes from proprietary pine-chemical refining technology, long-standing customer relationships, regulatory certifications for automotive carbon canisters, and scale in niche markets. These are defensible but not wide.	Medium-low
Management	CEO John Fortson has led the company since its WestRock spinoff in 2016. Management has grown revenue through M&A and organic investment, but large impairment charges in 2025 raise questions about capital allocation discipline.	Medium
Financial trend	TTM revenue was about $1.21 billion. The company reported large impairment-driven GAAP losses in 2025, with TTM GAAP net loss reflected in negative EPS of $3.55. Adjusted operating results have remained positive.	Medium
Valuation	The stock trades at roughly 2.1x TTM revenue and an undefined P/E due to negative GAAP earnings. The valuation reflects a cyclical chemicals business with recovery potential but carries execution risk.	Low
Technical trend	NGVT has rallied from a 52-week low of $39.74 to $72.07, approaching the 52-week high of $79.28. Momentum is positive but the stock is entering a resistance zone.	Medium-high
Risk level	Key risks are further impairment charges, elevated debt leverage, cyclical demand in pavement and oilfield markets, raw material cost volatility, automotive EV transition risk for activated carbon, and single-company concentration in pine chemical supply.	Medium
AI confidence	Medium confidence for revenue trajectory, segment trends, and market data. Lower confidence for the timing of margin recovery and the sustainability of the current valuation multiple.	Medium data confidence
Investment certainty	Low-medium certainty. NGVT has recovery momentum and real assets, but the impairment overhang, debt load, and cyclicality demand a higher margin of safety than the current price provides.	Low-medium

NGVT AI stock forecast

NGVT AI Stock Forecast Scenarios

The NGVT AI stock forecast uses scenario ranges around the $72.07 cutoff price. It does not claim that AI can predict a specific future price. The bullish case requires sustained recovery in pavement preservation and oilfield markets, successful margin improvement, and no further large impairments. The base case assumes moderate growth with continued debt reduction. The bearish case assumes end-market weakness or additional impairment charges.

Bullish case

$90 to $105

More likely if Ingevity delivers sustained revenue growth, operating margins expand toward historical levels, debt is reduced meaningfully, and the market assigns a higher multiple on improved earnings power.

Base case

$60 to $80

More likely if revenue grows modestly, margins stabilize but do not fully recover, and the stock trades in line with mid-cycle specialty chemical valuations at roughly 1.5-2.5x revenue.

Bearish case

$40 to $55

More likely if a recession reduces demand in pavement and automotive markets, raw material costs spike, additional impairment charges emerge, or the company faces covenant pressure on its debt.

NGVT AI technical analysis

NGVT AI Technical Analysis

NGVT AI technical analysis starts from the $72.07 close used for this July 13 static page. Public technical sources showed the stock well above its 52-week low of $39.74 and approaching the 52-week high of $79.28. Because this page does not fetch request-time market data, traders should confirm levels on a live chart before acting.

Level	Value	Why it matters
Current price	$72.07	Latest verified close used for this page as of the July 13, 2026 data cutoff.
Near support	$63 to $67	Support planning zone around the 50-day moving average area reported by public technical sources.
Secondary support	$55 to $58	The 200-day moving average area. A sustained break below this zone would weaken the recovery narrative.
Near resistance	$79 to $80	The 52-week high zone near $79.28. A clean breakout above $80 with volume could open room toward $85.
50-day moving average	About $63 to $67	Public technical sources showed NGVT above its 50-day moving average around the cutoff.
200-day moving average	About $55 to $58	Public technical sources showed NGVT above its 200-day moving average, supporting the medium-term uptrend.
Momentum	RSI in mid-to-high range	After the rally from $39.74 to $72.07, momentum has carried the stock upward, though short-term oscillators suggest the move is maturing.
Volume	About 285,000 shares average	Volume near the 285,000 average suggests the recovery rally has had normal participation.
Volatility	Beta of 1.16, moderate volatility	Position sizing should account for normal daily swings in a mid-cap specialty chemical stock.
Invalidation	Close below $63, then $55	A close below the 50-day area weakens the near-term recovery bias. A break below the 200-day area would challenge the broader uptrend.

NGVT AI trading strategy

NGVT AI Trading Strategy Framework

The NGVT AI trading strategy is a rules-based framework, not personalized advice. It combines filing-backed business evidence, technical confirmation, position sizing, and clear invalidation levels.

Trend-following setup

Look for NGVT to hold above the $63 to $67 support zone and break above the $79 to $80 resistance area with above-average volume before treating the recovery trend as confirmed.

A failed breakout or daily close below the 50-day area should reduce confidence in the setup.

Mean-reversion setup

If NGVT pulls back toward the $63 to $67 zone without a thesis break, compare price stabilization with upcoming earnings, segment margin data, and debt reduction progress signals.

Do not average down solely because the stock has recovered from its low. Define maximum loss and review the impairment and leverage risks first.

Fundamental monitor

Track quarterly revenue by segment, operating margins, debt-to-EBITDA ratio, free cash flow generation, and any further impairment announcements.

Lower the rating if revenue growth stalls while debt remains elevated, or if additional material impairment charges emerge.

Investment research summary

Four-master Research Compression

Business essence

Ingevity extracts and refines specialty chemicals from pine trees (Performance Chemicals) and manufactures activated carbon (Performance Materials), selling into pavement preservation, oilfield, automotive, and industrial markets.

Moat

The moat is built on proprietary pine-chemical refining technology, long-term customer contracts, regulatory approvals for automotive carbon canisters, and manufacturing scale in niche markets. Competitors would need significant time and capital to replicate the integrated pine-to-chemicals supply chain.

Munger risk inversion

The thesis can fail if end-market demand weakens (pavement, automotive, oilfield), raw material costs rise, the company records further large impairment charges, debt covenants become restrictive, or the EV transition reduces long-term demand for automotive activated carbon.

Management

CEO John Fortson has led Ingevity since its 2016 spinoff from WestRock. Management has executed M&A and invested in growth, but the 2025 impairment charges signal that prior acquisitions or assets did not perform as expected.

Industry trend

Ingevity operates in mature chemical markets tied to infrastructure spending, automotive production, and oilfield activity. The long-term trend is moderate growth with cyclicality, though environmental regulations for automotive emissions provide a steady tailwind for activated carbon.

Valuation and margin of safety

At roughly 2.1x TTM revenue and negative GAAP earnings, the stock prices in a recovery in earnings power. A buyer needs confidence in margin improvement and debt reduction to justify the current level.

Source-backed data

NGVT Data Table

Every metric below includes a source and last verification date.

Metric	Value	Source	Last verified
NGVT price	$72.07 close on July 10, 2026	Google Finance quote snapshot	July 13, 2026
Market capitalization	$2.51 billion as of recent close	Google Finance and SEC filings	July 13, 2026
TTM revenue	Approximately $1.21 billion	Google Finance quarterly revenue data	July 13, 2026
TTM GAAP EPS	-$3.55	Google Finance key statistics	July 13, 2026
Q1 2026 revenue	$258.00 million	Google Finance quarterly income statement	July 13, 2026
Shares outstanding	34.77 million	Google Finance and SEC filings	July 13, 2026
Enterprise value	Approximately $3.5 billion (estimated)	Derived from market cap plus estimated net debt	July 13, 2026
Price to sales ratio (TTM)	Approximately 2.1x	Derived from market cap and TTM revenue	July 13, 2026
Analyst consensus	Mixed, average price target $80.00	Google Finance analyst ratings (BMO Buy $85, Wells Fargo Hold $75)	July 13, 2026
52-week range	$39.74 to $79.28	Google Finance statistics	July 13, 2026
Beta	1.16	Google Finance statistics	July 13, 2026

Frequently Asked Questions

Read the IOSP AI stock analysis View the FUL AI stock forecast Explore AI Stock Picker Generate an AI trading strategy

This NGVT AI stock analysis is an informational tool for research and education only. It is not investment advice, a recommendation, or a guarantee of future performance. Forecast ranges are scenarios based on available data as of July 13, 2026 and can be wrong.